Hypoxic preconditioning induces the expression of prosurvival and proangiogenic markers in mesenchymal stem cells.

Stem cells transplanted to the ischemic myocardium usually encounter massive cell death within a few days of therapy. Hypoxic preconditioning (HPC) is currently employed as a strategy to prepare stem cells for increased survival and engraftment in the heart. However, HPC of stem cells has provided varying results, supposedly due to the differences in the oxygen concentration, duration of exposure, and passage conditions. In the present study, we determined the effect of HPC on rat mesenchymal stem cells (MSCs) exposed to 0.5% oxygen concentration for 24, 48, or 72 h. We evaluated the expression of prosurvival, proangiogenic, and functional markers such as hypoxia-inducible factor-1α, VEGF, phosphorylated Akt, survivin, p21, cytochrome c, caspase-3, caspase-7, CXCR4, and c-Met. MSCs exposed to 24-h hypoxia showed reduced apoptosis on being subjected to severe hypoxic conditions. They also had significantly higher levels of prosurvival, proangiogenic, and prodifferentiation proteins when compared with longer exposure (72 h). Cells taken directly from the cryopreserved state did not respond effectively to the 24-h HPC as those that were cultured under normoxia before HPC. Cells cultured under normoxia before HPC showed decreased apoptosis, enhanced expression of connexin-43, cardiac myosin heavy chain, and CD31. The preconditioned cells were able to differentiate into the cardiovascular lineage. The results suggest that MSCs cultured under normoxia before 24-h HPC are in a state of optimal expression of prosurvival, proangiogenic, and functional proteins that may increase the survival and engraftment in the infarct heart. These results could provide further insights into optimal preparation of MSCs which would greatly influence the effectiveness of cell therapy in vivo.

[1]  P. Kuppusamy,et al.  Oxygen and oxygenation in stem-cell therapy for myocardial infarction. , 2010, Life sciences.

[2]  A. Curt,et al.  Stem cells in the treatment of chronic spinal cord injury: evaluation of somatosensitive-evoked potentials in 39 patients , 2010, Spinal Cord.

[3]  Xinbin Chen,et al.  Examination of the expanding pathways for the regulation of p21 expression and activity. , 2010, Cellular signalling.

[4]  Eric Farrell,et al.  The role of hypoxia in bone marrow-derived mesenchymal stem cells: considerations for regenerative medicine approaches. , 2010, Tissue engineering. Part B, Reviews.

[5]  Young-ho Kim Mesenchymal stem cells cultured under hypoxia escape from senescence via down-regulation of p16 and extracellular signal regulated kinase , 2010 .

[6]  D. Mozaffarian,et al.  Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association's Strategic Impact Goal Through 2020 and Beyond , 2010, Circulation.

[7]  Ingo Müller,et al.  Low physiologic oxygen tensions reduce proliferation and differentiation of human multipotent mesenchymal stromal cells , 2010, BMC Cell Biology.

[8]  D. Meldrum,et al.  PRECONDITIONING MESENCHYMAL STEM CELLS WITH TRANSFORMING GROWTH FACTOR-ALPHA IMPROVES MESENCHYMAL STEM CELL-MEDIATED CARDIOPROTECTION , 2010, Shock.

[9]  J. Minguell,et al.  Bone marrow-derived stem/progenitor cells: their use in clinical studies for the treatment of myocardial infarction. , 2009, Heart, lung & circulation.

[10]  P. Kuppusamy,et al.  Myocardial oxygenation and functional recovery in infarct rat hearts transplanted with mesenchymal stem cells. , 2009, American journal of physiology. Heart and circulatory physiology.

[11]  Jun Jiang,et al.  Anoxic preconditioning: a way to enhance the cardioprotection of mesenchymal stem cells. , 2009, International journal of cardiology.

[12]  B. Dawn,et al.  Bone marrow-derived mesenchymal stems cells and cardiac repair. , 2009, Minerva cardioangiologica.

[13]  Meijing Wang,et al.  Estradiol-treated mesenchymal stem cells improve myocardial recovery after ischemia. , 2009, Journal of Surgical Research.

[14]  W. Teixeira,et al.  Stem cells in the treatment of chronic spinal cord injury: evaluation of somatosensitive evoked potentials in 39 patients , 2009, Spinal Cord.

[15]  W. Grossman,et al.  VEGF improves survival of mesenchymal stem cells in infarcted hearts. , 2008, Biochemical and biophysical research communications.

[16]  Ling Wei,et al.  Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. , 2008, The Journal of thoracic and cardiovascular surgery.

[17]  A. Ragnarsson,et al.  Anterior myocardial infarction with acute percutaneous coronary intervention and intracoronary injection of autologous mononuclear bone marrow cells: safety, clinical outcome, and serial changes in left ventricular function during 12-months' follow-up. , 2008, Journal of the American College of Cardiology.

[18]  Yuri Kim,et al.  Oxygen and Cell Fate Decisions , 2008, Gene regulation and systems biology.

[19]  J. Zweier,et al.  Skeletal myoblasts transplanted in the ischemic myocardium enhance in situ oxygenation and recovery of contractile function. , 2007, American journal of physiology. Heart and circulatory physiology.

[20]  Feng Zhao,et al.  Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells. , 2007, Biochemical and biophysical research communications.

[21]  Darwin J. Prockop,et al.  Short-Term Exposure of Multipotent Stromal Cells to Low Oxygen Increases Their Expression of CX3CR1 and CXCR4 and Their Engraftment In Vivo , 2007, PloS one.

[22]  K. Rudolph,et al.  A Dual Role of p21 in Stem Cell Aging , 2007, Annals of the New York Academy of Sciences.

[23]  G. Gerstenblith,et al.  Preconditioning stem cells for cardiovascular disease: an important step forward. , 2007, Circulation Research.

[24]  R. Zhao,et al.  Proliferation and differentiation of bone marrow stromal cells under hypoxic conditions. , 2006, Biochemical and biophysical research communications.

[25]  M. Ratajczak,et al.  Migration of Bone Marrow and Cord Blood Mesenchymal Stem Cells In Vitro Is Regulated by Stromal‐Derived Factor‐1‐CXCR4 and Hepatocyte Growth Factor‐c‐met Axes and Involves Matrix Metalloproteinases , 2006, Stem cells.

[26]  J. Ingwall,et al.  Evidence supporting paracrine hypothesis for Akt‐modified mesenchymal stem cell‐mediated cardiac protection and functional improvement , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  P. Poole‐Wilson,et al.  The dying stem cell hypothesis: immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle. , 2005, Journal of the American College of Cardiology.

[28]  M. Csete,et al.  Oxygen in the Cultivation of Stem Cells , 2005, Annals of the New York Academy of Sciences.

[29]  M. Teh,et al.  Ex vivo differentiation of human adult bone marrow stem cells into cardiomyocyte-like cells. , 2004, Biochemical and biophysical research communications.

[30]  Gerhard Ehninger,et al.  Mesenchymal Stem Cells Can Be Differentiated Into Endothelial Cells In Vitro , 2004, Stem cells.

[31]  B. Fleischmann,et al.  Bone marrow–derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation , 2004, Nature Medicine.

[32]  P. Poole‐Wilson,et al.  Regenerative capacity of the myocardium: implications for treatment of heart failure , 2004, The Lancet.

[33]  Y. Geng Molecular Mechanisms for Cardiovascular Stem Cell Apoptosis and Growth in the Hearts with Atherosclerotic Coronary Disease and Ischemic Heart Failure , 2003, Annals of the New York Academy of Sciences.

[34]  N. Ferrara,et al.  The biology of VEGF and its receptors , 2003, Nature Medicine.

[35]  K Walsh,et al.  Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. , 2001, Journal of molecular and cellular cardiology.

[36]  S. R. Datta,et al.  Cellular survival: a play in three Akts. , 1999, Genes & development.

[37]  G. Sirugo,et al.  Induction of Apoptosis and Inhibition of Cell Proliferation bysurvivin Gene Targeting* , 1998, The Journal of Biological Chemistry.

[38]  M. Olivotto,et al.  The role of hypoxia in the maintenance of hematopoietic stem cells. , 1993, Blood.

[39]  Lisa J. Harris,et al.  The role of hypoxia in stem cell differentiation and therapeutics. , 2011, The Journal of surgical research.

[40]  S. Cheong,et al.  Cryopreserved mesenchymal stromal cell treatment is safe and feasible for severe dilated ischemic cardiomyopathy. , 2010, Cytotherapy.

[41]  C. Taylor Mitochondria and cellular oxygen sensing in the HIF pathway. , 2008, The Biochemical journal.

[42]  Jun Jiang,et al.  Hypoxic preconditioning attenuates hypoxia/reoxygenation-induced apoptosis in mesenchymal stem cells , 2008, Acta Pharmacologica Sinica.

[43]  J. Kastrup,et al.  The influence of freezing and storage on the characteristics and functions of human mesenchymal stromal cells isolated for clinical use. , 2007, Cytotherapy.

[44]  Paul D. Kessler,et al.  Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart , 2002, Circulation.